Literature DB >> 20653631

Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/ PD-L1 pathway.

Celine S Lages1, Ian Lewkowich, Alyssa Sproles, Marsha Wills-Karp, Claire Chougnet.   

Abstract

Programmed cell death-1 (PD-1) is a newly characterized negative regulator of immune responses. The interaction of PD-1 with its ligands (PD-L1 and PD-L2) inhibits T-cell proliferation and cytokine production in young mice. Increased PD-1 expression has been described during chronic infections, inducing chronic activation of the immune system to control it. As aging is associated with chronic immune activation, PD-1 may contribute to age-associated T-cell dysfunction. Our data showed the following results in aged mice: (i) the number of PD-1-expressing T cells and the level of expression of PD-Ls was increased on dendritic cell subsets and T cells; (ii) PD-1(+) T cells were exhausted effector memory T cells, as shown by their lower level of CD127, CD25 and CD28, as well as their limited proliferative and cytokine-producing capacity; (iii) the expression of PD-1 was up-regulated after T-cell receptor-mediated activation of CD8(+) T cells, but not of CD4(+) T cells; (iv) blockade of the PD-1/PD-L1 pathway moderately improved the cytokine production of T cells from old mice but did not restore their proliferation; and (v) blockade of the PD-1/PD-L1 pathway did not restore function of PD-1(+) T cells; its effect appeared to be exclusively mediated by increased functionality of the PD-1(-) T cells. Our data thus suggest that blockade of the PD-1/PD-L1 is not likely to be efficient at restoring exhausted T-cell responses in aged hosts, although improving the responses of PD-1(-) T cells may prove to be a helpful strategy in enhancing primary responses.
© 2010 The Authors Aging Cell © 2010 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20653631      PMCID: PMC2941565          DOI: 10.1111/j.1474-9726.2010.00611.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  58 in total

1.  Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma.

Authors:  Takatoshi Shimauchi; Kenji Kabashima; Daiki Nakashima; Kazunari Sugita; Yoko Yamada; Ryosuke Hino; Yoshiki Tokura
Journal:  Int J Cancer       Date:  2007-12-15       Impact factor: 7.396

2.  Advancing age leads to predominance of inhibitory receptor expressing CD4 T cells.

Authors:  Rudragouda Channappanavar; Brandon S Twardy; Pratima Krishna; Susmit Suvas
Journal:  Mech Ageing Dev       Date:  2009-08-26       Impact factor: 5.432

3.  B7-H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK).

Authors:  Her Jun; Su K Seo; Hye-Young Jeong; Hyoun-Mi Seo; Gefeng Zhu; Lieping Chen; In-Hak Choi
Journal:  FEBS Lett       Date:  2005-10-19       Impact factor: 4.124

4.  Interaction of human PD-L1 and B7-1.

Authors:  Manish J Butte; Victor Peña-Cruz; Mi-Jung Kim; Gordon J Freeman; Arlene H Sharpe
Journal:  Mol Immunol       Date:  2008-06-27       Impact factor: 4.407

5.  Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.

Authors:  Liqing Wang; Rongxiang Han; Wayne W Hancock
Journal:  Eur J Immunol       Date:  2007-10       Impact factor: 5.532

6.  Age-associated up-regulation of a negative co-stimulatory receptor PD-1 in mouse CD4+ T cells.

Authors:  Yukiko Shimada; Masami Hayashi; Yasuhiko Nagasaka; Yoshiko Ohno-Iwashita; Mitsushi Inomata
Journal:  Exp Gerontol       Date:  2009-05-18       Impact factor: 4.032

7.  Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation.

Authors:  Celine S Lages; Isabelle Suffia; Paula A Velilla; Bin Huang; Gregg Warshaw; David A Hildeman; Yasmin Belkaid; Claire Chougnet
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

8.  PD-1+ memory phenotype CD4+ T cells expressing C/EBPalpha underlie T cell immunodepression in senescence and leukemia.

Authors:  Kenichiro Shimatani; Yasuhiro Nakashima; Masakazu Hattori; Yoko Hamazaki; Nagahiro Minato
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-08       Impact factor: 11.205

9.  PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.

Authors:  Guoping Peng; Shuping Li; Wei Wu; Xufei Tan; Yiqiong Chen; Zhi Chen
Journal:  Mol Immunol       Date:  2007-09-14       Impact factor: 4.407

10.  Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.

Authors:  Shawn D Blackburn; Haina Shin; W Nicholas Haining; Tao Zou; Creg J Workman; Antonio Polley; Michael R Betts; Gordon J Freeman; Dario A A Vignali; E John Wherry
Journal:  Nat Immunol       Date:  2008-11-30       Impact factor: 25.606

View more
  54 in total

1.  Finding Balance: T cell Regulatory Receptor Expression during Aging.

Authors:  Mary M Cavanagh; Qian Qi; Cornelia M Weyand; Jörg J Goronzy
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

2.  Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer.

Authors:  Christine Mall; Gail D Sckisel; David A Proia; Annie Mirsoian; Steven K Grossenbacher; Chien-Chun Steven Pai; Mingyi Chen; Arta M Monjazeb; Karen Kelly; Bruce R Blazar; William J Murphy
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

3.  Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes.

Authors:  Scott M J Cornwall; Matthew Wikstrom; Arthur W Musk; John Alvarez; Anna K Nowak; Delia J Nelson
Journal:  Oncoimmunology       Date:  2015-08-31       Impact factor: 8.110

Review 4.  NAD+ metabolism and its roles in cellular processes during ageing.

Authors:  Anthony J Covarrubias; Rosalba Perrone; Alessia Grozio; Eric Verdin
Journal:  Nat Rev Mol Cell Biol       Date:  2020-12-22       Impact factor: 94.444

Review 5.  Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults.

Authors:  Rawad Elias; Joshua Morales; Carolyn Presley
Journal:  Curr Oncol Rep       Date:  2017-09       Impact factor: 5.075

6.  Defective CD8 T cell responses in aged mice are due to quantitative and qualitative changes in virus-specific precursors.

Authors:  Vilma Decman; Brian J Laidlaw; Travis A Doering; Jin Leng; Hildegund C J Ertl; Daniel R Goldstein; E John Wherry
Journal:  J Immunol       Date:  2012-01-13       Impact factor: 5.422

Review 7.  Considerations for successful cancer immunotherapy in aged hosts.

Authors:  V Hurez; Á S Padrón; R S Svatek; T J Curiel
Journal:  Clin Exp Immunol       Date:  2016-11-07       Impact factor: 4.330

8.  Two separate defects affecting true naive or virtual memory T cell precursors combine to reduce naive T cell responses with aging.

Authors:  Kristin R Renkema; Gang Li; Angela Wu; Megan J Smithey; Janko Nikolich-Žugich
Journal:  J Immunol       Date:  2013-11-29       Impact factor: 5.422

9.  Increased T-bet is associated with senescence of influenza virus-specific CD8 T cells in aged humans.

Authors:  Douglas V Dolfi; Kathleen D Mansfield; Antonio M Polley; Susan A Doyle; Gordon J Freeman; Hanspeter Pircher; Kenneth E Schmader; E John Wherry
Journal:  J Leukoc Biol       Date:  2013-02-25       Impact factor: 4.962

Review 10.  Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity.

Authors:  Rudragouda Channappanavar; Stanley Perlman
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.